Home > Boards > US OTC > Biotechs >

Pharmaxis Ltd. (PXSLY)

PXSLY RSS Feed
Add PXSLY Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 7/23/2015 3:29:23 PM - Followers: 0 - Board type: Free - Posts Today: 0

Pharmaxis Ltd. 20 Rodborough Road Frenchs Forest, NSW 2086 Australia Phone: 61 2 9454 7200 Fax: 61 2 9451 3622 Website: http://www.pharmaxis.com.au Pharmaxis Ltd, a specialty pharmaceutical company, engages in the research, development, and commercialization of human healthcare products for the treatment and management of respiratory and other chronic diseases worldwide. The company’s lead product and product candidates are used for the diagnosis and treatment of chronic respiratory diseases, including asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD), including bronchiectasis and chronic bronchitis, and other chronic and acute pulmonary conditions. It offers Aridol lung function test, which is designed to assist physicians in the assessment of asthma by identifying and measuring airway hyperresponsiveness; and Bronchitol, a drug designed to reduce the amount of mucus build-up in the lungs of patients suffering from chronic respiratory conditions. The company’s early product development pipeline includes orbital dry powder inhaler that delivers drug doses to the lungs; Lysyl Oxidase Like 2 (LOXL-2) inhibitors for the treatment of fibrosis; PXS64/25 targeting lung fibrosis; ASM8 targeting severe asthma; and PXS TPI1100 for the treatment candidate for COPD. Pharmaxis Ltd was founded in 1998 and is headquartered in Frenchs Forest, Australia.
PXSLY
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PXSLY News: Boehringer Ingelheim Acquires Pharmaxis' Phase 1 Anti-inflammatory Drug Candidate 05/17/2015 10:18:00 PM
PXSLY News: Boehringer Ingelheim Acquires Pharmaxis' Phase 1 Anti-inflammatory Drug Candidate 05/17/2015 10:03:00 PM
PXSLY News: NICE Approves Pharmaxis' Bronchitol® As An Important New Treatment Option For Cystic Fibrosis Patients 10/26/2012 05:00:00 AM
PXSLY News: Pharmaxis Receives Approval to Market Bronchitol in the EU 04/27/2012 04:00:00 AM
PXSLY News: Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit J-code 01/03/2012 12:56:00 PM
PostSubject
#1   $PXSLY recent news/filings stocktrademan 07/23/15 03:29:23 PM
PostSubject